The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

4 Jun 2015 07:00

RNS Number : 1424P
Oxford Advanced Surfaces Group PLC
04 June 2015
 



OXFORD ADVANCED SURFACES GROUP PLC

(AIM: OXA)

 4 June 2015

 

Appointment of a director

 

The Board of Oxford Advanced Surfaces Group Plc the AIM listed technology developer targeting a number of global markets including automotive, aerospace, electronics and renewable energy, is pleased to announce the appointment as a non - executive director of Michael Anthony Bretherton with immediate effect.

 

 

From 2006 to 2014 Mr. Bretherton, who is 59, was an executive director of ORA Capital Partners Ltd. In August 2014 he became Executive Chairman of AIM listed Sarossa plc which invests in technology companies.

 

Mr Bretherton owns 3,173,824 shares in the Company, representing approximately 1.6 per cent of the shares in issue.

 

Save for the information disclosed below there is no other information to be disclosed under Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies in relation to Mr Bretherton's appointment as a Director of the Company other than as follows:

 

Current directorships

 

Past Directorships

Adams Plc

Abway Enterprises Corp

Blake Holdings Limited

Ceres Power Holdings Plc

ORA Charitable Trust Limited

Foram Properties Limited

ORA Limited

Nanoco Group Plc

Sarossa Plc

Nanoco Tech Limited

Obtala Limited

Obtala Resources Limited

Obtala Services Limited

ORA Capital Partners Limited

ORA Capital Services Limited

ORA Guernsey Limited

ORA Land Limited

ORA Properties Limited

Oxford Advanced Surfaces Group Plc

Oxford Pharmascience Group Plc

Oxford Pharmascience Limited

Oxford Nutra Limited

Oxray Limited

Sarossa Capital Limited

Tissue Regenix Group Plc

 

In addition, Mr Bretherton was a non-executive director of Brimley & Co. Limited, a wholly owned subsidiary of Bridgend Group Plc, until the acquisition of Bridgend Group by HemScott Holdings Limited in August 2000 and at which time Mr Bretherton resigned. Following the acquisition and Mr Bretherton's resignation, the assets and business of Brimley were sold and that company was put into creditors' voluntary liquidation in October 2000 with a resulting net deficit to external creditors of £168,000.

 

Contacts:

Oxford Advances Surfaces Group Plc

www.oxfordsurfaces.com

James Ede-Golightly - Chairman

T: 01865 854 807

W H Ireland Limited

www.wh-ireland.co.uk

John Wakefield

T: 0117 945 3470

Editors' Note

 

Oxford Advanced Surfaces Group plc designs, develops and manufactures surface modification technology to address the bonding challenges of advanced materials in the automotive, aerospace, electronics and renewable energy markets. Our proprietary platform technology, Onto™ highly reactive chemistry, provides manufacturers with versatile solutions for even to the most difficult‑to-bond substrates such as engineering plastics, thermoplastic composites and carbon-based materials. Onto™ surface treatments can be integrated into existing manufacturing facilities for use in a wide range of surface functionalisation and adhesion promotion applications.

 

www.oxfordsurfaces.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMGGVDFNGKZM
Date   Source Headline
5th Jan 20237:00 amRNSCancellation - DEEPMATTER GROUP PLC
4th Jan 20238:00 amRNSHolding(s) in Company
29th Dec 20225:30 pmRNSDeepmatter Group
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20223:44 pmRNSResult of General Meeting
19th Dec 20222:05 pmRNSSecond Price Monitoring Extn
19th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 202211:05 amRNSSecond Price Monitoring Extn
19th Dec 202211:00 amRNSPrice Monitoring Extension
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
9th Dec 202211:05 amRNSSecond Price Monitoring Extn
9th Dec 202211:00 amRNSPrice Monitoring Extension
8th Dec 20228:46 amRNSHolding(s) in Company
2nd Dec 20227:00 amRNSPosting of Circular
1st Dec 20227:00 amRNSProposed Cancellation of Ordinary Shares
24th Nov 20227:00 amRNSCorporate Update
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading Update
26th Oct 20227:00 amRNSDeepMatter signs multi-year license agreement
26th Aug 20221:25 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHalf Year Results
28th Jun 20227:00 amRNSDeepMatter acquires AI specialist ChemIntelligence
20th Jun 20224:41 pmRNSSecond Price Monitoring Extn
20th Jun 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20222:05 pmRNSSecond Price Monitoring Extn
20th Jun 20222:00 pmRNSPrice Monitoring Extension
20th Jun 202211:05 amRNSSecond Price Monitoring Extn
20th Jun 202211:00 amRNSPrice Monitoring Extension
9th Jun 20225:26 pmRNSHolding(s) in Company
27th May 20222:30 pmRNSResult of AGM
25th May 20222:30 pmRNSIssue of Equity and TVR
23rd May 20227:00 amRNSDirectorate Change
20th May 20227:00 amRNSContract extension
11th May 20227:00 amRNSContract
27th Apr 20227:00 amRNSFinal Results
30th Mar 20224:00 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSContract
14th Feb 20227:00 amRNSDirector/PDMR Shareholding
26th Jan 20223:20 pmRNSHolding(s) in Company
26th Jan 20223:15 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSHolding(s) in Company
25th Jan 20225:45 pmRNSHolding(s) in Company
25th Jan 202212:30 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.